Novartis Aktie
101,00
EUR
+20,90
EUR
+26,09
%
94,25
CHF
+0,46
CHF
+0,49
%
Werbung
Novartis Aktie Analyse
20.12.21 | Novartis Buy | Jefferies & Company Inc. | |
20.12.21 | Novartis Underweight | JP Morgan Chase & Co. | |
17.12.21 | Novartis Sell | Deutsche Bank AG | |
16.12.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
16.12.21 | Novartis Underweight | JP Morgan Chase & Co. | |
16.12.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
16.12.21 | Novartis Buy | Jefferies & Company Inc. | |
14.12.21 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
Werbung
|
|||
13.12.21 | Novartis Neutral | Credit Suisse Group | |
07.12.21 | Novartis Buy | Jefferies & Company Inc. | |
06.12.21 | Novartis Sell | Deutsche Bank AG | |
03.12.21 | Novartis Neutral | UBS AG | |
03.12.21 | Novartis Underweight | JP Morgan Chase & Co. | |
26.11.21 | Novartis Neutral | UBS AG | |
11.11.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
10.11.21 | Novartis Buy | Jefferies & Company Inc. | |
05.11.21 | Novartis Neutral | UBS AG | |
04.11.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
04.11.21 | Novartis Underweight | JP Morgan Chase & Co. | |
27.10.21 | Novartis Underweight | Barclays Capital | |
27.10.21 | Novartis Sell | Deutsche Bank AG | |
27.10.21 | Novartis Underweight | JP Morgan Chase & Co. | |
27.10.21 | Novartis Neutral | Credit Suisse Group | |
26.10.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
26.10.21 | Novartis Buy | UBS AG | |
26.10.21 | Novartis Underweight | JP Morgan Chase & Co. | |
26.10.21 | Novartis Sell | Deutsche Bank AG | |
25.10.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
25.10.21 | Novartis Underweight | JP Morgan Chase & Co. | |
25.10.21 | Novartis Buy | UBS AG | |
14.10.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
12.10.21 | Novartis Market-Perform | Bernstein Research | |
11.10.21 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
08.10.21 | Novartis Buy | UBS AG | |
07.10.21 | Novartis Buy | Jefferies & Company Inc. | |
05.10.21 | Novartis Underweight | JP Morgan Chase & Co. | |
20.09.21 | Novartis Sell | Deutsche Bank AG | |
17.09.21 | Novartis Hold | Deutsche Bank AG | |
14.09.21 | Novartis Underweight | JP Morgan Chase & Co. | |
13.09.21 | Novartis Hold | Deutsche Bank AG | |
06.09.21 | Novartis Hold | Kepler Cheuvreux | |
04.08.21 | Novartis Buy | UBS AG | |
28.07.21 | Novartis Underweight | JP Morgan Chase & Co. | |
27.07.21 | Novartis Overweight | Morgan Stanley | |
23.07.21 | Novartis Buy | UBS AG | |
22.07.21 | Novartis Hold | Deutsche Bank AG | |
22.07.21 | Novartis Neutral | Credit Suisse Group | |
22.07.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
21.07.21 | Novartis Market-Perform | Bernstein Research | |
21.07.21 | Novartis Market-Perform | Bernstein Research |
Werbung
Werbung